There is 1 paper on DAPL1 in aging research: none in people yet, 1 in animals.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Animals1
Effects
4E2F1ANDC-MYC
downin mouse cells1
1 study
E2F1ANDC-MYC
downin mouse cells1
DAPL1 decreases E2F1ANDC-MYC in mouse cells.
“DAPL1 suppresses the expression of E2F1 and c-MYC.”
Cellsretinal pigment epithelium
Journal of the Formosan Medical Association = Taiwan yi zhi
mTOR signaling
downin mouse cells1
1 study
mTOR signaling
downin mouse cells1
DAPL1 inhibits mTOR signaling in RPE cells, via suppression of E2F1 and c-MYC.
“This downregulates mTOR and upregulates the expression of ATG16 and Beclin1 through DAPK1 in RPE cells, promoting autophagy.”
Cellsin RPE cells, via suppression of E2F1 and c-MYCretinal pigment epithelium
Journal of the Formosan Medical Association = Taiwan yi zhi
Age-dependent retinal pathologies
downin mice1
1 study
Age-dependent retinal pathologies
downin mice1
DAPL1 protects against age-dependent retinal pathologies in mice (shown by knockout at 18 months of age).
“Dapl1-deficient mice exhibit age-related retinal dysfunction and structural abnormalities.”
Animalsshown by knockout at 18 months of ageretina
Journal of the Formosan Medical Association = Taiwan yi zhi
Autophagy
upin mouse cells1
1 study
Autophagy
upin mouse cells1
DAPL1 increases autophagy in mouse cells (shown by overexpression in RPE cells).
“DAPL1 overexpression in RPE cells enhances autophagy activity.”
Cellsshown by overexpression in RPE cellsretinal pigment epithelium
Journal of the Formosan Medical Association = Taiwan yi zhi